franca, do not waste your time responding to liars like dansmile and semenface. they are almost certainly children posting for pennies from their mom's basement. They post no factual info. and their agenda is clear.
thanks for your contributions.
oncologist prescribe "off-label" all the time, as long as it's approved in a cancer indication. One oncologist I collaborated with at U.Penn said "I will use whatever I think will work."
who you talking about when you say "we"? you are as transparent as semenface and just as stupid if you think your posts carry any weight.
that you semenface?
if you had half of one brain you know better than to expose your stupidity by posting on this mb.
this isn't about emotions - this is blatant manipulation by them that know. I was buying ARIA in 2009 for less than $1.50/sh. Already had a small position and loaded up when it got beat into the dirt by shorts and hedge funds. Only got to $25/sh before the FDA flagged 'em on tox (blood clots) - dropped to less than $3. Oncologists raised hell with FDA because they knew how effective ARIA's drug was for CML patients that had failed previous therapies. ARIA is making a comeback; bouncing around $6-8 over past year and may get back into $20s in next year or so.
Knew the science was there and it was just a matter of time. Quadrupled my initial investment and still hold a ton of shares. Probably should have sold more when it was in the $20s but thought it might run higher. Same story happening with EXEL - it's just a matter of time. Anybody talking about this company going into bankruptcy is either out of their mind or flat lying. Most of the posters on this mb saying EXEL is going to be bankrupt are liars. Actually it may only be one guy posting under multiple aliases. Most common alias is semenreservoir or semenface posting from his mom's basement day and night. Only a moronic, mean-spirited kid would spend the time he does on this mb.
Wilderguide hasn't been around as long as some other longs but his impact on this mb has been huge.
Wilder, hope you are well and still with us. Completely understand your silence.
Well said wilder. Spoken like a scientist. You may have missed your true calling - but sounds like you would have been successful and enjoyed anything you chose to do.
.... current sp is being held in check by large investors and tutes to prevent any possibility of more dilution by issuing more shares. We longs have had it with EXEL management and those in position to dictate sp are doing so by keeping it under $2. EXEL cannot remain a viable entity by issuing more shares here. Management can make their big salaries but that's temporary and they will be hard-pressed to get equivalent positions in future given their performance at EXEL. Management stands to lose the real money (stock options) and have poor prospects for future employment if they screw this up more than they already have. Big investors and tutes are holding EXEL management's feet to the fire and have taken away the option of dilution. This should make for interesting discussions in negotiating any deals EXEL management is engaged in.
2015 is going to be pretty interesting.
Longs should be buying here.
agreed, but somehow I have a hard time feeling sorry for them. They are very well-paid but not excessive for the sector. But way too many mistakes were made in everything from trial design to financing. Some of these mistakes were due to ignorance but others were pure arrogance and hubris. I think part of the reason sp is so low is that some of the big investors want to punish EXEL management and force some resolution. These investors have taken their pound of flesh and then some. Many of these big investors probably sold and bought back cheap. Others threw in the towel with big losses. So far the only people making money on EXEL are short traders which is really too bad.
yeah valley, definitely not a scam and management is plenty motivated to have some sort of success with EXEL. only questions now are how long and how much, because surely this needs to come to an end at some point. it doesn't look like the huge $$$$ EXEL management and longs were hoping for but it will be manyfold over where we are today.
hang on valley.
Morrissey would have to spend close to $4 million to buy stock that is worth a little more than $1million at todays closing price. Quite the deal, eh?
Management has plenty of skin in the game - in many ways they are in the same boat as longs. Yes, they are highly paid but the big money is in the options they've had issued to them over the years. Anybody that thinks they don't care about current sp doesn't know what they're talking about.
I don't think they can do that. They are options. Legally those prices are set based on sp when they were issued. They are worthless today.
yeah duck - these guys are the real deal. Most are world-class scientists and others have loads of experience in venture cap space and biotech. You can bet they're not panicking at current sp. People are looking for management to buy at these prices. How many are selling?
Apparently, YMB only allows so many characters/post. below is what I was going to close with on previous post.....
EXEL drugs are effective and there is value here and I am more than willing to wait and take advantage of sp due to shorts driving this into the dirt. EXEL will be back, just like ARIA with ONE approved drug in very narrow indication (CML) and for patients that fail standard care therapies (Gleevec, etc). With ARIA, I made my money back, plus triple my initial investment in profit and still own 60% of my shares.
Anybody here play poker? besides wilder - I know he plays.